News

Atacama Labs Oy has developed an oral drug delivery technology (called ‘pneumatic dry granulation’ or ‘PDG Technology. The technology is aimed at replacing existing solid dosage form development

Reportedly, AuroSource is expected to partner with pharma firms globally and cultivate opportunities to research, manufacture and develop compounds across the entire drug life cycle. Aurobindo said that

The study results also showed numerically lower rates of major and clinically relevant non-major bleeding in patients treated with apixaban compared with those treated with enoxaparin. The results

Hizentra, a once weekly immunoglobulin (Ig) replacement therapy, provides effective protection against infection by maintaining a steady and normal level of immunoglobulin in the body. CSL Behring claimed

LIMS-on-Demand can reduce the capital investment associated with traditional LIMS implementation and validation by eliminating the need for extensive software testing and installation. On-demand access provides a more

OmniComm claimed that TrialOne provides all necessary web-based tools used to recruit study volunteers, schedule screening appointments, collect screening data, directly capture real-time data, track sample transfers and

GOG is a multidisciplinary cooperative clinical trial research group focused on the study of gynecologic malignancies. GOG is conducting Phase III trials in ovarian cancer and other gynecologic

Health Sciences International, based in Connecticut, aims to conduct quality phase I-IV trial research with key therapeutic areas of focus including cardiology, vascular disorders, CNS, endocrinology and internal

In the Connection trial, Dimebon did not meet its co-primary or secondary efficacy endpoints compared to placebo. Co-primary endpoints were measures of cognition and global function. Dimebon was